🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the side effects and best dose of FT-2102 wh...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-08-27
Trial ID
NCT04013880
Treatments Being Tested
This phase I trial tests the safety, side effects, and best dose of nivolum...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2022-11-03
Trial ID
NCT05272384
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Status
Active Not Recruiting
Location
Mayo Clinic Hospital in Arizona
Start Date
2020-09-08
Trial ID
NCT04340843
This phase II trial studies the effect of ASTX727 and dasatinib in treating...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-10-21
Trial ID
NCT05007873
Treatments Being Tested
This study is designed to examine blood levels of ASTX727, a fixed-dose com...
Status
Completed
Location
Roswell Park
Start Date
2018-11-08
Trial ID
NCT03813186
Treatments Being Tested
To evaluate the safety, pharmacokinetics (PK), and efficacy of ASTX660 when...
Status
Terminated
Location
University of California San Francisco
Start Date
2020-06-12
Trial ID
NCT04155580
To learn if ASTX727 given alone or in combination with donor lymphocyte inf...
Status
Withdrawn
Location
MD Anderson Cancer Center
Start Date
2024-07-01
Trial ID
NCT06297629
Treatments Being Tested
The purpose of this study is to see whether the study drug ASTX727 is an ef...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2021-04-29
Trial ID
NCT04872543
Treatments Being Tested
This phase II trial studies the effects of venetoxlax in combination with d...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-09-29
Trial ID
NCT04975919
Treatments Being Tested
This is a Phase 1b, multicenter, open-label, pharmacokinetic (PK), and safe...
Status
Recruiting
Location
MD Anderson
Start Date
2022-12-23
Trial ID
NCT04953910
Treatments Being Tested